Effects of Lemon Verbena Extract Supplementation in Sub-ADHD Children
NCT05476549, Not applicable, Completed, Northumbria University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of Lemon Verbena Extract Supplementation in Sub-ADHD Children | ClinicalTrials.gov |
| NCT number | NCT05476549 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 140 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Northumbria University | ClinicalTrials.gov |
| Conditions | Behavior, Child, Cognitive Change | ClinicalTrials.gov |
| Interventions | Lemon verbena, Placebo | ClinicalTrials.gov |
| First posted | 2022-07-27 | ClinicalTrials.gov |
| Last updated | 2023-12-11 | ClinicalTrials.gov |
Registered outcomes 37
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Conners 3 score from baseline to 8 weeks, parent rating | Baseline to 8 weeks | ClinicalTrials.gov | |
| Primary | Change in Conners 3 score from baseline to 8 weeks, child rating | Baseline to 8 weeks | ClinicalTrials.gov | |
| Primary | Change in total mood disturbance from baseline to 8 weeks | Baseline to 8 weeks | Profile of mood states questionnaire | ClinicalTrials.gov |
| Primary | Change in depression-dejection from baseline to 8 weeks | Baseline to 8 weeks | Profile of mood states questionnaire | ClinicalTrials.gov |
| Primary | Change in tension-anxiety from baseline to 8 weeks | Baseline to 8 weeks | Profile of mood states questionnaire | ClinicalTrials.gov |
| Primary | Change in anger-hostility from baseline to 8 weeks | Baseline to 8 weeks | Profile of mood states questionnaire | ClinicalTrials.gov |
| Primary | Change in confusion-bewilderment from baseline to 8 weeks | Baseline to 8 weeks | Profile of mood states questionnaire | ClinicalTrials.gov |
| Primary | Change in vigour-activity from baseline to 8 weeks | Baseline to 8 weeks | Profile of mood states questionnaire | ClinicalTrials.gov |
| Primary | Change in fatigue-inertia from baseline to 8 weeks | Baseline to 8 weeks | Profile of mood states questionnaire | ClinicalTrials.gov |
| Primary | Change in systolic blood pressure from baseline to 8 weeks | Baseline to 8 weeks | Systolic blood pressure (mmHg) | ClinicalTrials.gov |
| Primary | Change in diastolic blood pressure from baseline to 8 weeks | Baseline to 8 weeks | Diastolic blood pressure (mmHg) | ClinicalTrials.gov |
| Primary | Change in body temperature from baseline to 8 weeks | Baseline to 8 weeks | Degrees Celsius | ClinicalTrials.gov |
| Primary | Change in RMSSD during the performance of cognitive tasks from baseline to 8 weeks | Baseline to 8 weeks | Root mean square of successive differences between normal heartbeats (RMSSD) | ClinicalTrials.gov |
| Primary | Change in heart rate during the performance of cognitive tasks from baseline to 8 weeks | Baseline to 8 weeks | Beats per minute | ClinicalTrials.gov |
| Primary | Change in heart rate variability index during the performance of cognitive tasks from baseline to 8 weeks | Baseline to 8 weeks | Heart rate variability index | ClinicalTrials.gov |
| Primary | Change in pNN50 during the performance of cognitive tasks from baseline to 8 weeks | Baseline to 8 weeks | pNN50 is the mean number of times per hour in which the change in consecutive normal sinus (NN) intervals exceeds 50 milliseconds. | ClinicalTrials.gov |
| Primary | Change in stress index during the performance of cognitive tasks from baseline to 8 weeks | Baseline to 8 weeks | The stress index is a measure of the ratio between the parasympathetic and sympathetic tone. intervals exceeds 50 milliseconds. | ClinicalTrials.gov |
| Primary | Change in subjective anxiety from baseline to 8 weeks | Baseline to 8 weeks | State-trait anxiety inventory (STAI) total score | ClinicalTrials.gov |
| Primary | Change in subjective perceived stress from baseline to 8 weeks | Baseline to 8 weeks | Perceived stress scale (PSS) total score | ClinicalTrials.gov |
| Primary | Change in subjective mood from baseline to 8 weeks, alertness | Baseline to 8 weeks | Visual analogue scale composite score | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Corsi Block-Tapping Test | Primary outcome | ConductCognition |
| Eriksen Flanker Task | Primary outcome | ConductCognition |
| Rapid Visual Information Processing | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)